Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck to develop new class of antibacterials

October 6, 2010
Research and Development BioRelix, Merck & Co, anti-infectives

Merck & Co has signed a drug development agreement with anti-infective pharma firm BioRelix to development a new class of …

News

Intercell Biomedical appoints site director

October 6, 2010
Manufacturing and Production, Research and Development Intercell, appointment, research and development

Austrian biotech Intercell Biomedical has appointed Eric Frings as site director of its Livingston, Scotland operations.He joins the firm from …

Appointment

Novartis drops two drug candidates, takes $600 million hit

October 6, 2010
Research and Development Human Genome Sciences, Novartis, candidiasis, hepatitis

Novartis will incur a charge of nearly $600 million after it halted development of investigational drugs for hepatitis C and …

News

Talking R&D: eCTD challenges

October 6, 2010
Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The eCTD was of course developed by the ICH (International Conference on Harmonisation) Expert Working Group to make it easier, …

Feature
GSK’s Seretide/Advair

New COPD and asthma treatments jostle for market space

October 6, 2010
Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma

Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …

Feature

Uncertainty over new cancer fund

October 6, 2010
Sales and Marketing Cancer, NHS, government

The UK government has launched its £50 million interim fund to give greater access to new cancer medicines. The new …

News

Janssen leads the pack at PM Society Digital Awards

October 6, 2010
Medical Communications Janssen, PM Society Digital Awards, disease awareness campaigns, pm society

Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …

News

New Commercial Realities – Part 4 Key implications of this changing industry landscape for pharmaceutical commercial operations – governance

October 5, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature
White paper

Chris Brinsmead joins the Board of Kinapse

October 5, 2010
Kinapse

London, UKThe Board of Directors of Kinapse Ltd. is delighted to announce that Chris Brinsmead has agreed to become a …

News
Press release

GSK takes stake in biotech spin-out

October 5, 2010
Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding

GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …

News
Elan facility

Elan debuts manufacturing services business

October 5, 2010
Manufacturing and Production Elan

Irish pharmaceutical company Elan marked its official entry into the solid dose contract manufacturing sector today at the ongoing CPhI …

News

Recipharm buys Abbott plant to enter Spanish market

October 5, 2010
Manufacturing and Production Abbott, Recipharm, Solvay

Swedish contract development and manufacturing services company Recipharm has agreed to buy a facility in Parets del Valles, Spain, from …

News

Digital Pharma: Pfizer socialises pain campaign

October 5, 2010
Medical Communications Digital Pharma blog, Facebook, Flickr, Pfizer, Twitter, social media

Pfizer is campaigning for better care for people suffering from chronic pain and has turned to social media to galvanise …

News

Svend Andersen to lead Hospira in Europe

October 5, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing

US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …

Appointment

Talking R&D: Evolving technical standards

October 5, 2010
Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The European Union (EU) Module 1 specification works in parallel with the ICH eCTD Specification. It was first introduced in …

Feature

Sanofi makes hostile offer for Genzyme

October 4, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …

News

Managing the Franchise

October 4, 2010
Sales and Marketing branding, marketing, product portfolio

Commercial managers who are responsible for a number of brands face a constant dilemma in choosing where across the franchise …

Feature

Mitsui boosts contract manufacturing business

October 4, 2010
Manufacturing and Production API, Arch Pharmalabs, India, Mitsui

Mitsui & Co has taken a 5% stake in Indian active pharmaceutical ingredients manufacturer Arch Pharmalabs in a $13 million …

News

Further expansion for Doctors.net.uk pharma team

October 4, 2010
Sales and Marketing Doctors.net.uk, GPs, communications, doctors, pharma marketing

 New hires to support and drive rapid growth  

News
Press release

GSK drops herpes vaccine

October 4, 2010
Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health

Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026